ArticleJournal of nanobiotechnology2025

PDLIM4 drives gastric cancer malignant progression and cisplatin resistance by inhibiting HSP70 ubiquitination and degradation via competitive interaction with STUB1.

Chao Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.